Sarcopenia in Older Adults Undergoing Transcatheter Aortic Valve Replacement
The evaluation of frailty is a critical task for risk prediction and patient selection in older adults referred for transcatheter aortic valve replacement (TAVR) ([1][1]). Sarcopenia is one of the biological substrates of frailty that has attracted interest because muscle mass and strength can be